National Agency of Drug and Food Control, Indonesia Newly Confirmed Present at 2nd Annual Pharma Regulatory Affairs Asia

Jan 23, 2012 10:00 JST

Source: Pharma Regulatory Affairs

SINGAPORE, Jan 23, 2012 - (ACN Newswire) - "Asia regulations keep on changing, in particular in all the established countries like China and Japan. Another change is that many countries don't have regulations at the moment but they are going to have new regulations (e.g. drug-medical device combined product) coming, so they will uniquely register in their country very soon. In the past, you didn't need it. An example of this is India, Hong Kong, Singapore, Malaysia, etc. So there will be two major dynamics that I think companies need to be aware of," said Jack Wong, Regulatory Affairs Director, Johnson and Johnson Medical.

Indeed, like what Jack has mentioned, ensuring regulatory compliance has become one of the biggest challenges for products development in Asia.

Jack Wong will be speaking at the 2nd Annual Pharma Regulatory Affairs Asia conference, which will take place on 25-26 April 2012 in Singapore.

In China, what's the impact of the healthcare system reform on pharma companies?

In Korea, what's the impact of recently IND Regulation changes and what's the next step of regulation updates?

In Vietnam, what is the regulation framework for drug registration and product commercialisation?

In Indonesia, what are the new regulations related to pre-market evaluation?

The 2nd Annual Pharma Regulatory Affairs Asia conference will feature speakers from Thailand FDA, National Agency of Drug and Food Control, Indonesia, DIA, APEC Harmonization Centre, Novartis, AstraZeneca, Johnson & Johnson among the others, and will discuss pharma regulation updates and regulatory compliance in China, India, Korea, Thailand, Vietnam, Indonesia and Philippines.

Drop an email to enquiry@iqpc.com.sg to register for the conference or visit www.pharmaregulatoryaffairsasia.com for the full list of speakers and topics that will be covered at the 2nd Annual Pharma Regulatory Affairs Asia.

Contact:

Bryan Camoens
IQPC Worldwide
Tel: +65-67229406
Email: bryan.camoens@iqpc.com.sg

Source: Pharma Regulatory Affairs
Sectors: Trade Shows, BioTech

Latest Release

International Land Alliance Unveils New Revenue Model Featuring 100 Rental Homes in Cabo Oasis
Jul 16, 2025 22:00 JST

Eisai Awarded "The 9th Bioindustry Award" for Drug Discovery Research for Anti- Amyloid B Monoclonal Antibody Lecanemab
Jul 16, 2025 14:50 JST

New Trains for Singapore's Sengkang-Punggol LRT Begin Commercial Operation
Jul 16, 2025 14:34 JST

AUG East Consortium and NEC to develop high-capacity submarine cable system across East Asia
Jul 16, 2025 14:00 JST

Anime Tokyo Station: Mobile Suit Gundam GQuuuuuuX -Beginning- Special Exhibition - New Designs Added for Admission Bonus Illustration Cards
Jul 16, 2025 11:00 JST

Fujitsu Data Intelligence PaaS enhances Mazda's data-utilization and decision-making
Jul 16, 2025 10:30 JST

Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection
Jul 16, 2025 10:20 JST

All Nippon Airways and Hitachi Unveil Japan's First Airline "Operations Brain" System, Enabling Rapid, Optimal Flight Schedule Revisions During Disruptions
Jul 15, 2025 12:00 JST

Fujitsu's AI-powered supply chain solution selected as transformative example of applied-AI technology by World Economic Forum
Jul 14, 2025 10:30 JST

"URECE" (Dotinurad) Launched in China as a treatment for Gout
Jul 14, 2025 10:20 JST

Mitsubishi Motors Added to FTSE4Good Index Series, FTSE Blossom Japan Index and FTSE Blossom Japan Sector Relative Index for Consecutive Years
Jul 11, 2025 16:28 JST

All-New MAZDA CX-5 Debuts in Europe
Jul 10, 2025 18:56 JST

Sharp Signs Official Partnership with Tottenham Hotspur FC Pre-season Tour 2025 with Its AQUOS Brand
Jul 10, 2025 17:30 JST

Hitachi develops "Metaverse Platform for Nuclear Power Plants" to enhance efficiency in construction and maintenance operations
Jul 09, 2025 19:02 JST

"Development of Integrated Simulation Platform for Sustainable and Competitive Maritime Industry" has been selected as a R&D project under K Program
Jul 08, 2025 20:30 JST

Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment
Jul 08, 2025 09:31 JST

MHI Awarded Contract for Basic Design of Japan's Largest CO2 Capture Plant at Hokkaido Electric Power's Tomato-Atsuma Power Station
Jul 07, 2025 11:15 JST

Fujitsu's high-precision skeleton recognition AI adopted to enhance figure skating athlete training
Jul 05, 2025 13:40 JST

DENSO Acquires Axia Vegetable Seeds to Realize Sustainable Agriculture
Jul 04, 2025 16:20 JST

MHIET Launches 450kW Gas Cogeneration System Capable of Hydrogen Co-Firing
Jul 04, 2025 15:13 JST

More Latest Release >>